Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
TGTX holding history
TG Therapeutics, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TGTX overviewAll 13F holders of TGTXFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −557,966−100.0% | Sold out | Holders |
| Q2 2025 | 557,966 | $20.1M | 0.1% | +557,966 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −195,212−100.0% | Sold out | Holders |
| Q4 2021 | 195,212 | $3.71M | <0.1% | −1,118,576−85.1% | Reduced | Holders |
| Q3 2021 | 1,313,788 | $43.7M | 0.1% | −1,512,974−53.5% | Reduced | Holders |
| Q2 2021 | 2,826,762 | $109.7M | 0.3% | −1,868,539−39.8% | Reduced | Holders |
| Q1 2021 | 4,695,301 | $226.3M | 0.6% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.